Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...
Richard Pieris and Company PLC reported a 32% decrease in net profit of Rs.35.6 million for the nine months ended 31 December 2009 compared to a net profit of Rs.52.6 million for the corresponding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback